Biosimilars - A Major Future Market
Sandoz is the pioneer and undisputed global leader in the rapidly emerging market for biosimilars, also known as follow-on biologics (or biopharmaceuticals).
In 2010, the US Congress established for the first time a regulatory pathway for the approval of biosimilars. Sandoz already brings affordable, high-quality biosimilars like Omnitrope®, Binocrit® and Zarzio® to patients in many markets around the world, providing greater access to these state-of-the-art treatments.
Visit our stand-alone Sandoz Biosimilars Website to find out more about why biologics matter, how biosimilars are broadening access to these essential medicines, and why Sandoz is leading the way.
Biosimilars in the US News
As a newly developing area of affordable medicine in the US, biosimilars is frequently in the news. Below find links to articles of interest related to the future of biosimilars in the US.
Related content
FAQs: Generics
Everything you wanted to know about the generics industry.
Product Finder
Use our Product Finder tool to search our product database by brand or generic name!
Customer Information
Are you a Customer and looking for information about Customer Connect, EDI, policies, etc.?